MSB 1.73% $1.18 mesoblast limited

I think the actual point being made about the vastly changed...

  1. 102 Posts.
    lightbulb Created with Sketch. 252
    I think the actual point being made about the vastly changed treatment landscape was that early in the trial people were being put on ventilation once their condition deteriorated whereas in the latter half of this year ventilation was no longer a normal treatment but rather a last resort. So not only does this mean that enrollment was slower, but the odds of saving them was much reduced. The trial had a few restrictions but with the benefit of hindsight it should have restricted enrolment to patients within a few days of ICU admission, but had this been in place we likely would have had no enrolments. The treatment landscape just changed too much across the time of the trial.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.18
Change
0.020(1.73%)
Mkt cap ! $1.341B
Open High Low Value Volume
$1.20 $1.21 $1.17 $16.67M 14.04M

Buyers (Bids)

No. Vol. Price($)
5 54704 $1.18
 

Sellers (Offers)

Price($) Vol. No.
$1.18 10000 1
View Market Depth
Last trade - 16.10pm 07/05/2024 (20 minute delay) ?
Last
$1.19
  Change
0.020 ( 3.40 %)
Open High Low Volume
$1.21 $1.21 $1.17 2927691
Last updated 15.59pm 07/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.